An employee works in the lab of Hikma Pharmaceuticals in Amman, Jordan. The British drugmaker said it has signed a non-binding agreement with Glaxo Group for the potential sale of its entire stake of 91.2 per cent in its listed subsidiary GSK Egypt. Photo: Salah Malkawi / The National
An employee works in the lab of Hikma Pharmaceuticals in Amman, Jordan. The British drugmaker said it has signed a non-binding agreement with Glaxo Group for the potential sale of its entire stake of Show more
